GMPS
Basic information
Region (hg38): 3:155870649-155944020
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GMPS gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 26 | 27 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 26 | 0 | 5 |
Variants in GMPS
This is a list of pathogenic ClinVar variants found in the GMPS region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-155870895-A-C | not specified | Uncertain significance (Nov 13, 2023) | ||
3-155870906-G-T | Benign (Dec 31, 2019) | |||
3-155893564-A-T | not specified | Uncertain significance (Sep 12, 2023) | ||
3-155893698-C-T | not specified | Uncertain significance (Mar 11, 2022) | ||
3-155893704-A-G | Benign (Dec 31, 2019) | |||
3-155897934-A-G | not specified | Uncertain significance (Apr 28, 2022) | ||
3-155903941-A-G | not specified | Uncertain significance (Jun 02, 2023) | ||
3-155906242-C-T | not specified | Uncertain significance (Feb 17, 2024) | ||
3-155906261-C-A | not specified | Uncertain significance (May 03, 2023) | ||
3-155910748-C-T | not specified | Uncertain significance (Feb 16, 2023) | ||
3-155910818-C-T | not specified | Uncertain significance (Aug 02, 2023) | ||
3-155910873-G-A | Benign (Dec 31, 2019) | |||
3-155911256-A-G | not specified | Uncertain significance (Jul 12, 2022) | ||
3-155911265-G-A | not specified | Uncertain significance (Apr 19, 2024) | ||
3-155914509-C-T | not specified | Uncertain significance (Aug 17, 2022) | ||
3-155914549-C-T | Benign (Dec 31, 2019) | |||
3-155914560-C-A | not specified | Uncertain significance (Oct 05, 2021) | ||
3-155916180-G-T | not specified | Uncertain significance (Nov 17, 2022) | ||
3-155922241-A-C | not specified | Uncertain significance (Feb 06, 2024) | ||
3-155925257-A-G | not specified | Uncertain significance (Dec 07, 2023) | ||
3-155925365-A-G | not specified | Uncertain significance (Jun 24, 2022) | ||
3-155931774-C-T | not specified | Uncertain significance (Nov 13, 2023) | ||
3-155931787-A-C | Benign (Jun 18, 2018) | |||
3-155931790-T-C | not specified | Uncertain significance (Oct 10, 2023) | ||
3-155931859-G-A | not specified | Uncertain significance (Aug 16, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GMPS | protein_coding | protein_coding | ENST00000496455 | 16 | 73491 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.998 | 0.00175 | 124642 | 0 | 9 | 124651 | 0.0000361 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.37 | 228 | 353 | 0.645 | 0.0000174 | 4522 |
Missense in Polyphen | 66 | 145.51 | 0.45359 | 1834 | ||
Synonymous | 1.12 | 101 | 116 | 0.868 | 0.00000553 | 1332 |
Loss of Function | 4.73 | 3 | 31.7 | 0.0945 | 0.00000165 | 430 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000123 | 0.000123 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000559 | 0.0000556 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000445 | 0.0000442 |
Middle Eastern | 0.0000559 | 0.0000556 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in the de novo synthesis of guanine nucleotides which are not only essential for DNA and RNA synthesis, but also provide GTP, which is involved in a number of cellular processes important for cell division.;
- Disease
- DISEASE: Note=A chromosomal aberration involving GMPS is found in acute myeloid leukemias. Translocation t(3,11)(q25,q23) with KMT2A/MLL1.;
- Pathway
- Drug metabolism - other enzymes - Homo sapiens (human);Purine metabolism - Homo sapiens (human);Thiopurine Pathway, Pharmacokinetics/Pharmacodynamics;Purine Nucleoside Phosphorylase Deficiency;Mercaptopurine Action Pathway;Azathioprine Action Pathway;2-Hydroxyglutric Aciduria (D And L Form);Xanthine Dehydrogenase Deficiency (Xanthinuria);Adenylosuccinate Lyase Deficiency;AICA-Ribosiduria;Thioguanine Action Pathway;Adenine phosphoribosyltransferase deficiency (APRT);Mitochondrial DNA depletion syndrome;Myoadenylate deaminase deficiency;Purine Metabolism;Homocarnosinosis;Hyperinsulinism-Hyperammonemia Syndrome;Succinic semialdehyde dehydrogenase deficiency;Molybdenum Cofactor Deficiency;Adenosine Deaminase Deficiency;Mercaptopurine Metabolism Pathway;4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency;Gout or Kelley-Seegmiller Syndrome;Lesch-Nyhan Syndrome (LNS);Xanthinuria type I;Xanthinuria type II;Glutamate Metabolism;Metabolism of nucleotides;Metabolism;Nucleobase biosynthesis;Purine nucleotides nucleosides metabolism;superpathway of purine nucleotide salvage;Purine ribonucleoside monophosphate biosynthesis;guanosine nucleotides <i>de novo</i> biosynthesis;guanosine ribonucleotides <i>de novo</i> biosynthesis;purine nucleotides <i>de novo</i> biosynthesis
(Consensus)
Recessive Scores
- pRec
- 0.533
Intolerance Scores
- loftool
- 0.252
- rvis_EVS
- -0.25
- rvis_percentile_EVS
- 35.99
Haploinsufficiency Scores
- pHI
- 0.831
- hipred
- Y
- hipred_score
- 0.853
- ghis
- 0.659
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.987
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gmps
- Phenotype
Zebrafish Information Network
- Gene name
- gmps
- Affected structure
- iridophore
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- GMP biosynthetic process;glutamine metabolic process;purine nucleobase biosynthetic process;purine ribonucleoside monophosphate biosynthetic process
- Cellular component
- cytosol
- Molecular function
- GMP synthase activity;GMP synthase (glutamine-hydrolyzing) activity;ATP binding;pyrophosphatase activity